imatinib

Audio Journal of Oncology in Advance – March 15th, 2008+

16th March 2008

Volume 16 Number 6 (March 15th, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
Chemotherapy Foundation Symposium, November 7-10, 2007, New York

david maloney Audio Journal of Oncology in Advance   March 15th, 2008
David Maloney

Nonmyeloablative

Read More+

Live Report from ASH:
Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML+

10th December 2007

richard stone Live Report from ASH:<br />Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML” src=”http://www.audiomedica.com/img/asco/071209/richard_stone.jpg” /<br /> Richard Stone </div>
</p>
</div>
<div>
<div>
	    <strong> RICHARD STONE, Dana-Farber Cancer Institute, Boston<br />
GEORGE CANELLOS, Dana-Farber Cancer Institute</strong><br />
New data shows that dasatinib is giving durable responses in patients with chronic phase </div>
</div>
<p>…</p></div>
					<!--END .post-content -->
					
					</div>
					
					<a class=Read More+

ASCO Audio Journal of Oncology in Advance – December 15th, 2006 – Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006+

16th December 2006

martin muller ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Martin Müller
charles linker ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Charles Linker
andreas hochhaus ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Andreas Hochhaus
christian buske ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Christian Buske
katarina leblanc ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Katarina Le Blanc
stephen emerson ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Stephen Emerson
alessandro vannucchi ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Alessandro Vannucchi
kanti rai 1 ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Kanti Rai
richard schlenk ASCO Audio Journal of Oncology in Advance   December 15th, 2006   Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9 12, 2006
Richard Schlenk

BCR-ABL Mutations After Imatinib Failure: Impact on Response to Dasatinib

REFERENCE: American Society of Hematology 2006 Orlando: Abstract: 748
MARTIN MÜLLER,

Read More+

ASCO Audio Journal of Oncology – September 1st, 2006+

30th August 2006

060604mark socinski ASCO Audio Journal of Oncology   September 1st, 2006
Mark Socinski
060823bruce johnson ASCO Audio Journal of Oncology   September 1st, 2006
Bruce Johnson
060603neil shah ASCO Audio Journal of Oncology   September 1st, 2006
Neil Shah
060603doug smith ASCO Audio Journal of Oncology   September 1st, 2006
Doug Smith

Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer

REFERENCE: Abstract 7001
Mark A. Socinski, Univerisity of North Carolina, Chapel Hill
The use of anti-angiogenic therapy for treating patients with non-small cell

Read More+